Skip to main content
Back
CAC logo

Camden National Corporation

Data quality: 100%
CAC
NASDAQ Financial Services Banks - Regional
$46.57
▲ $1.31 (2.88%)
Mkt Cap: 788.13M
Day Range
$45.13 $47.35
52-Week Range
$34.53 $51.57
Volume
177,941
50D / 200D Avg
$47.10 / $41.98
Prev Close
$45.26

Price History

Financial Trends

Peer Comparison

vs Financial Services sector median (854 peers)

Metric Stock Sector Median
P/E 12.1 10.3
P/B 1.1 1.1
ROE % 10.6 11.7
Net Margin % 17.7 16.8
Rev Growth 5Y % 17.3 11.7
D/E 0.9 0.5

Analyst Price Target

No analyst coverage available

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 $5.90
$5.82 – $5.97
290 M 3
FY2026 $5.43
$5.40 – $5.45
280 M 3

Insider Trading Activity

18 transactions
Date Insider Type Shares Price Value
Mar 9, 2026
Ackley David
EVP
other 43 $45.83 $1,971
Mar 9, 2026
Boey Brandon Y
SVP
other 35 $45.83 $1,604
Feb 1, 2026
CHRISTMANN JOHN J
CEO
other 72,576
Jan 2, 2026
Sparks Paul Eugene
Director
grant 1,097,435
Dec 19, 2025
Maxwell Raina
Director
grant 312 $45.95 $14,336
Dec 19, 2025
Haynes Larry K
Director
grant 312 $45.95 $14,336
Sep 19, 2025
Haynes Larry K
Director
grant 357 $40.22 $14,359
Sep 19, 2025
Sterrs Lawrence J
Director
grant 195 $40.22 $7,843
Sep 19, 2025
Maxwell Raina
Director
grant 357 $40.22 $14,359
Jul 15, 2025
Ackley David
EVP
other 33 $41.58 $1,372
Jun 20, 2025
Hatfield Rebecca
Director
grant 383 $38.57 $14,772
Jun 20, 2025
Denekas Craig N
Director
grant 454 $38.57 $17,511
Jun 20, 2025
Maxwell Raina
Director
grant 307 $38.57 $11,841
May 30, 2025
Merrill Robert D
Director
grant 890
May 30, 2025
Hatfield Rebecca
Director
grant 890
May 28, 2025
Maxwell Raina
Director
buy 103 $40.09 $4,129
May 15, 2025
Ackley David
EVP
other 59 $41.49 $2,448
Apr 25, 2025
McKnight Garrett
EVP
other 109 $38.74 $4,223

Key Takeaways

Revenue grew 17.32% annually over 5 years — strong growth
Earnings grew 22.93% over the past year
ROE of 10.61% — decent returns on equity
Net margin of 17.74% shows strong profitability
Generating 59.52M in free cash flow
P/E of 12.10 — trading at a low valuation

Growth

Revenue Growth (5Y)
17.32%
Revenue (1Y)26.79%
Earnings (1Y)22.93%
FCF Growth (3Y)-4.23%

Quality

Return on Equity
10.61%
ROIC4.57%
Net Margin17.74%
Op. Margin22.22%

Safety

Debt / Equity
0.92
Current Ratio1.77
Interest Coverage0.70

Valuation

P/E Ratio
12.10
P/B Ratio1.13
EV/EBITDA16.35
Dividend Yield0.04%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 26.79% Revenue Growth (3Y) 21.14%
Earnings Growth (1Y) 22.93% Earnings Growth (3Y) 22.55%
Revenue Growth (5Y) 17.32% Earnings Growth (5Y) -1.43%
Profitability
Revenue (TTM) 367.34M Net Income (TTM) 65.16M
ROE 10.61% ROA 0.93%
Gross Margin 62.78% Operating Margin 22.22%
Net Margin 17.74% Free Cash Flow (TTM) 59.52M
ROIC 4.57% FCF Growth (3Y) -4.23%
Safety
Debt / Equity 0.92 Current Ratio 1.77
Interest Coverage 0.70 Dividend Yield 0.04%
Valuation
P/E Ratio 12.10 P/B Ratio 1.13
P/S Ratio 2.15 PEG Ratio 1.85
EV/EBITDA 16.35 Dividend Yield 0.04%
Market Cap 788.13M Enterprise Value 1.33B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 367.34M 289.72M 250.32M 208.89M 193.91M
Net Income 65.16M 53.00M 43.38M 61.44M 69.01M
EPS (Diluted) 3.84 3.62 2.97 4.17 4.60
Gross Profit 230.62M 172.11M 156.07M 179.29M 186.05M
Operating Income 81.62M 65.46M 53.84M 77.05M 86.64M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 6.97B 5.81B 5.71B 5.67B 5.50B
Total Liabilities 6.28B 5.27B 5.22B 5.22B 4.96B
Shareholders' Equity 696.56M 531.23M 495.06M 451.28M 541.29M
Total Debt 644.30M 544.95M 529.94M 309.51M 255.94M
Cash & Equivalents 97.49M 214.96M 99.80M 75.43M 220.63M
Current Assets 1.03B 787.51M 725.61M 771.30M 1.73B
Current Liabilities 581.78M 5.13B 5.18B 5.18B 4.91B

Strategy Scores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#704 of 1024
36

Recent Activity

Entered Cash Flow Compounder
Mar 24, 2026